北米のビタミンK2：2030年までの市場予測 - 地域分析 - 製品、剤形、由来、用途別

北米のビタミンK2市場は、2022年の6,389万米ドルから2030年には4億9,438万米ドルに成長すると予測されています。2022年から2030年までのCAGRは29.1%と推定されます。

CVDの有病率の増加が北米のビタミンK2市場を後押し

心血管疾患（CVD）は世界の健康上の重大な問題であり続けており、その有病率は近年着実に増加しています。この増加は、糖尿病、高コレステロール血症、高血圧などの危険因子の有病率の増加とともに、高齢化、座りがちなライフスタイル、食生活の乱れなどが原因となっています。世界保健機関（WHO）によると、CVDは世界的に毎年1,790万人が死亡する主要な死因です。

研究者たちは、CVDと闘うための様々な予防的・治療的アプローチを模索しています。その中で注目されているのが、心血管系の健康におけるビタミンK2の潜在的役割です。ビタミンK2（メナキノン）はビタミンKの一種で、心血管系への有益性が期待されています。ビタミンK2が心血管系の健康に影響を及ぼす重要なメカニズムは、カルシウム代謝を調節する役割です。動脈石灰化は、動脈壁にカルシウム沈着物が蓄積する過程であり、CVDの主要な根本原因であるアテローム性動脈硬化症の発症に寄与します。ビタミンK2は、カルシウム沈着を制御するのに役立つタンパク質を活性化することによって動脈石灰化を抑制し、動脈硬化および関連する心血管障害のリスクを低下させるという重要な役割を果たすことが判明しています。

いくつかの観察研究では、ビタミンK2の摂取とCVD転帰との関連性が検討されています。これらの研究は明確な因果関係を立証することはできないが、興味深い知見を提供しています。Journal of Nutrition誌による研究では、ビタミンK2の摂取量が多いほど冠動脈性心疾患の死亡リスクが低いことが明らかにされました。さらに、ビタミンK2は、生活習慣の改善と並んで、補助的な治療法あるいは予防法として考慮されるべきです。このような生活習慣の改善には、果物、全粒穀物、野菜、赤身のタンパク質を多く含むバランスのとれた食事を摂ること、健康的な体重を維持すること、定期的な運動を行うこと、血圧やコレステロール値を管理すること、喫煙習慣をやめることなどが含まれます。このように、CVDの有病率の増加が北米のビタミンK2市場を牽引しています。

北米のビタミンK2市場概要

北米のビタミンK2市場は米国、カナダ、メキシコに区分されます。同市場の成長は、CVD有病率の増加と成人および新生児の骨粗鬆症骨変形症例の増加に起因しています。しかし、ビタミンK2の利点に関する認知度が低いことが市場成長の妨げとなっています。北米の市場成長は、ビタミンK2の栄養補助食品の採用が増加していることにも起因しています。北米のビタミンK2市場で最大のシェアを占めるのは米国です。心血管疾患や骨粗鬆症、関節炎などの整形外科疾患の有病率の増加が、カルシウムやその他の栄養素の吸収を良くし、心臓や骨の健康を強化するビタミンK2の需要を高めています。米国疾病予防管理センター（CDC）によると、2021年には米国で～695,000人が心臓病で死亡し、冠動脈性心臓病が最も一般的な心臓病のタイプで、375,476人が死亡しました。さらに、同国では製品の上市、買収、合併など様々な戦略的開拓が行われており、これが市場の成長に寄与しています。2022年10月、Kappa Bioscience社は米国市場で初のオーガニックグレードのビタミンK2-MK7をK2Vitalのブランド名で発売しました。これは米国農務省（USDA）の有機認定を受けた米国市場初の油脂性健康用途のオールトランス型、オール生物活性ビタミンK2-MK7です。したがって、心血管疾患や整形外科疾患の有病率の上昇と戦略的協力関係の増加が、米国におけるビタミンK2市場の成長を促進すると予想されます。

北米のビタミンK2市場の収益と2030年までの予測（百万米国ドル）

北米のビタミンK2市場セグメンテーション

北米のビタミンK2市場は製品、剤形、供給源、用途、国に区分されます。

製品別では、北米のビタミンK2市場はMK-4、MK-7、配合剤に区分されます。2022年の北米のビタミンK2市場では、MK-7セグメントが最大のシェアを占めています。

剤形別では、北米のビタミンK2市場はカプセル＆錠剤、粉末、オイルに区分されます。2022年の北米のビタミンK2市場で最大のシェアを占めたのは粉末セグメントでした。

供給源に基づいて、北米のビタミンK2市場は天然と合成に区分されます。2022年の北米のビタミンK2市場は天然物セグメントが大きなシェアを占めています。

用途別では、北米のビタミンK2市場は医薬品、栄養補助食品、食品、その他に区分されます。医薬品セグメントが2022年の北米のビタミンK2市場で最大のシェアを占めています。

国別では、北米のビタミンK2市場は米国、カナダ、メキシコに区分されます。米国が2022年の北米のビタミンK2市場を独占しました。

Anderson Global Group LLC、Balchem Corp、BASF SE、Glanbia Plc、International Flavors &Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG、Novozymes ASは北米のビタミンK2市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

• 主要な洞察

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 北米のビタミンK2市場：主要産業力学

• 主な市場促進要因
  • CVDの有病率の増加
  • 成人および新生児における骨粗鬆症の症例増加
• 市場抑制要因
  • ビタミンK2の利点に関する認知度の低下
• 市場機会
  • 流通チャネルの拡大
• 今後の動向
  • 法規制と規格
• 影響分析

第5章 ビタミンK2市場：北米市場分析

• 北米のビタミンK2市場収益、2022-2030年

第6章 北米のビタミンK2市場 - 収益と2030年までの予測：製品別

• 市場収益シェア、2022年および2030年
• MK-4
• MK-7
• 併用剤

第7章 北米のビタミンK2市場 - 収益と2030年までの予測：剤形別

• 市場収益シェア、2022年および2030年
• カプセルと錠剤
• 粉末
• オイル

第8章 北米のビタミンK2市場 - 収益と2030年までの予測：由来別

• 市場収益シェア、2022年および2030年
• 天然
• 合成

第9章 北米のビタミンK2市場 - 収益と2030年までの予測：用途別

• 市場収益シェア、2022年および2030年
• 医薬品
• 栄養補助食品と食品
• その他

第10章 北米のビタミンK2市場：国別分析

• 北米、国別、2022年・2030年（%）
  • 米国
  • カナダ
  • メキシコ

第11章 ビタミンK2市場の業界情勢

• ビタミンK2市場の成長戦略
• 有機的成長戦略
• 無機的成長戦略

第12章 企業プロファイル

• Lonza Group AG
• International Flavors & Fragrances Inc
• Balchem Corp
• BASF SE
• Lesaffre et Cie SA
• Koninklijke DSM NV
• Novozymes AS
• Glanbia Plc
• Anderson Global Group LLC

第13章 付録

List Of Tables

• Table 1. North America Vitamin K2 Market Segmentation
• Table 2. US: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
• Table 3. US: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
• Table 4. US: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
• Table 5. US: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
• Table 6. Canada: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
• Table 7. Canada: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
• Table 8. Canada: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
• Table 9. Canada: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
• Table 10. Mexico: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
• Table 11. Mexico: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
• Table 12. Mexico: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
• Table 13. Mexico: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
• Table 14. Recent Organic Growth Strategies in Vitamin K2 Market
• Table 15. Recent Inorganic Growth Strategies in the Vitamin K2 Market
• Table 16. Glossary of Terms, North America Vitamin K2 Market

List Of Figures

• Figure 1. North America Vitamin K2 Market Segmentation, By Country
• Figure 2. North America Vitamin K2 Market - Key Industry Dynamics
• Figure 3. Impact Analysis of Drivers and Restraints
• Figure 4. North America Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
• Figure 5. North America Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
• Figure 6. MK-4: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 7. MK-7: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 8. Combination Drugs: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 9. North America Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
• Figure 10. Capsules and Tablets: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 11. Powder: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Oil: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. North America Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
• Figure 14. Natural: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 15. Synthetic: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. North America Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
• Figure 17. Pharmaceuticals: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 18. Nutraceuticals and Food: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. Others: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 20. North America Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 21. North America, by Country, 2022 & 2030 (%)
• Figure 22. US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 23. Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24. Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 25. Growth Strategies in Vitamin K2 Market

The North America vitamin K2 market is expected to grow from US$ 63.89 million in 2022 to US$ 494.38 million by 2030. It is estimated to grow at a CAGR of 29.1% from 2022 to 2030.

Increasing Prevalence of CVD Fuels North America Vitamin K2 Market

Cardiovascular disease (CVD) continues to be a significant global health concern, with its prevalence steadily increasing in recent years. This rise is due to the aging population, sedentary lifestyles, and poor dietary choices, along with the growing prevalence of risk factors, including diabetes, hypercholesterolemia, and hypertension. According to World Health Organization, CVD is a leading cause of death with ~17.9 million deaths every year globally.

Researchers are exploring various preventive and therapeutic approaches to combat CVD. One area of interest is the potential role of vitamin K2 in cardiovascular health. Vitamin K2, or menaquinone, is a form of vitamin K linked to potential cardiovascular benefits. A critical mechanism by which vitamin K2 impacts cardiovascular health is its role in regulating calcium metabolism. Arterial calcification, the process of calcium deposits accumulating in the arterial walls, contributes to the development of atherosclerosis, a major underlying cause of CVD. Vitamin K2 has been found to play a significant role in inhibiting arterial calcification by activating proteins that help regulate calcium deposition, thus reducing the risk of atherosclerosis and related cardiovascular disorders.

Several observational studies have examined the potential association between vitamin K2 intake and CVD outcomes. While these studies are unable to establish a definitive cause-and-effect relationship, they have provided interesting insights. A study by the Journal of Nutrition found that higher vitamin K2 intake was linked to a lower risk of coronary heart disease mortality. Further, vitamin K2 should be considered a potential adjunctive therapy or preventive measure alongside lifestyle changes. These modifications include adopting a balanced diet rich in fruits, whole grains, vegetables, and lean proteins; maintaining a healthy weight; engaging in regular physical activity; managing blood pressure and cholesterol levels; and stopping smoking habits. Thus, the increasing prevalence of CVD is driving the North America vitamin K2 market.

North America Vitamin K2 Market Overview

The North America Vitamin K2 market is segmented into the US, Canada, and Mexico. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. The market growth in North America is also attributed to the rising adoption of nutraceutical supplements for vitamin K2. The US accounts for the largest share of the vitamin K2 market in North America. The increasing prevalence of cardiovascular diseases and orthopedic disorders, such as osteoporosis and arthritis, has increased the demand for vitamin K2, as it helps in the better absorption of calcium and other nutrients, strengthening cardiac and bone health. According to the Centers for Disease Control and Prevention (CDC), in 2021, ~695,000 people died from heart disease in the US, coronary heart disease being the most common type of heart disease that resulted in the death of 375,476 people in the country. Moreover, various strategic developments such as product launches, acquisitions, and mergers have been taking place in the country, which are contributing to the market growth. In October 2022, Kappa Bioscience launched its first organic grade vitamin K2-MK7 in the US market under the brand name K2Vital. It is the first US Department of Agriculture (USDA) organic-certified all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications in the US market. Therefore, the rising prevalence of cardiovascular diseases and orthopedic disorders, along with an increase in strategic collaboration, is expected to drive the vitamin K2 market growth in the US.

North America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)

North America Vitamin K2 Market Segmentation

The North America vitamin K2 market is segmented into product, dosage forms, source, application, and country.

Based on product, the North America vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the North America vitamin K2 market in 2022.

Based on dosage forms, the North America vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the North America vitamin K2 market in 2022.

Based on source, the North America vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the North America vitamin K2 market in 2022.

Based on application, the North America vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the North America vitamin K2 market in 2022.

Based on country, the North America vitamin K2 market is segmented into the US, Canada, and Mexico. The US dominated the North America vitamin K2 market in 2022.

Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS are some of the leading companies operating in the North America vitamin K2 market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. North America Vitamin K2 Market - Key Industry Dynamics

• 4.1 Key Market Drivers:
  • 4.1.1 Increasing Prevalence of CVD
  • 4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
• 4.2 Market Restraints
  • 4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
• 4.3 Market Opportunities
  • 4.3.1 Expansion of Distribution Channel
• 4.4 Future Trends
  • 4.4.1 Regulatory Consideration and Standards
• 4.5 Impact Analysis:

5. Vitamin K2 Market - North America Market Analysis

• 5.1 North America Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

6. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

• 6.1 Overview
• 6.2 North America Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
• 6.3 MK-4
  • 6.3.1 Overview
  • 6.3.2 MK-4: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 MK-7
  • 6.4.1 Overview
  • 6.4.2 MK-7: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• 6.5 Combination Drugs
  • 6.5.1 Overview
  • 6.5.2 Combination Drugs: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

• 7.1 Overview
• 7.2 North America Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
• 7.3 Capsules and Tablets
  • 7.3.1 Overview
  • 7.3.2 Capsules and Tablets: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Powder
  • 7.4.1 Overview
  • 7.4.2 Powder: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Oil
  • 7.5.1 Overview
  • 7.5.2 Oil: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

• 8.1 Overview
• 8.2 North America Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
• 8.3 Natural
  • 8.3.1 Overview
  • 8.3.2 Natural: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Synthetic
  • 8.4.1 Overview
  • 8.4.2 Synthetic: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

• 9.1 Overview
• 9.2 North America Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
• 9.3 Pharmaceuticals
  • 9.3.1 Overview
  • 9.3.2 Pharmaceuticals: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Nutraceuticals and Food
  • 9.4.1 Overview
  • 9.4.2 Nutraceuticals and Food: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Others
  • 9.5.1 Overview
  • 9.5.2 Others: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Vitamin K2 Market - Country Analysis

• 10.1.1 North America, by Country, 2022 & 2030 (%)
  • 10.1.1.1 US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 Overview
    • 10.1.1.1.2 US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.3 US: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 10.1.1.1.4 US: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 10.1.1.1.5 US: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 10.1.1.1.6 US: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 10.1.1.2 Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Overview
    • 10.1.1.2.2 Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.3 Canada: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 10.1.1.2.4 Canada: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 10.1.1.2.5 Canada: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 10.1.1.2.6 Canada: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 10.1.1.3 Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Overview
    • 10.1.1.3.2 Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.3 Mexico: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 10.1.1.3.4 Mexico: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 10.1.1.3.5 Mexico: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 10.1.1.3.6 Mexico: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)

11. Vitamin K2 Market Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in Vitamin K2 Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Lonza Group AG
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 International Flavors & Fragrances Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Balchem Corp
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 BASF SE
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Lesaffre et Cie SA
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Koninklijke DSM NV
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Novozymes AS
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Glanbia Plc
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Anderson Global Group LLC
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms